Tirzepatide, a groundbreaking therapy, represents a significant innovation in the treatment of type 2 diabetes and, more recently, obesity. This dual agonist acts upon two crucial chemicals: incretin hormone and GIP. Unlike traditional diabetes drugs, Tirzepatide encourages not only production of insulin when glucose levels are elevated but also su